[2-(aminomethyl)-6-methylmorpholin-4-yl]-(1-methylindazol-3-yl)methanone

C15H20N4O2 — CID 103123263

IUPAC[2-(aminomethyl)-6-methylmorpholin-4-yl]-(1-methylindazol-3-yl)methanone
SMILESCC1CN(C(=O)c2nn(C)c3ccccc23)CC(CN)O1
InChIInChI=1S/C15H20N4O2/c1-10-8-19(9-11(7-16)21-10)15(20)14-12-5-3-4-6-13(12)18(2)17-14/h3-6,10-11H,7-9,16H2,1-2H3
InChIKeyCQHCYQSJSPATOS-UHFFFAOYSA-N
MW288.35 g/mol
LogP0.76
Rot. Bonds2

About [2-(aminomethyl)-6-methylmorpholin-4-yl]-(1-methylindazol-3-yl)methanone

[2-(aminomethyl)-6-methylmorpholin-4-yl]-(1-methylindazol-3-yl)methanone (PubChem CID 103123263) has the molecular formula C15H20N4O2 and a molecular weight of 288.35 g/mol. Its IUPAC name is [2-(aminomethyl)-6-methylmorpholin-4-yl]-(1-methylindazol-3-yl)methanone.

Molecular Properties

Compound Name[2-(aminomethyl)-6-methylmorpholin-4-yl]-(1-methylindazol-3-yl)methanone
PubChem CID103123263
Molecular FormulaC15H20N4O2
Molecular Weight288.35 g/mol
Exact Mass288.16
IUPAC Name[2-(aminomethyl)-6-methylmorpholin-4-yl]-(1-methylindazol-3-yl)methanone
SMILESCC1CN(C(=O)c2nn(C)c3ccccc23)CC(CN)O1
InChIInChI=1S/C15H20N4O2/c1-10-8-19(9-11(7-16)21-10)15(20)14-12-5-3-4-6-13(12)18(2)17-14/h3-6,10-11H,7-9,16H2,1-2H3
InChIKeyCQHCYQSJSPATOS-UHFFFAOYSA-N
XLogP0.76
TPSA73.38 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds2
Heavy Atoms21
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500288.35
LogP ≤ 50.76
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze [2-(aminomethyl)-6-methylmorpholin-4-yl]-(1-methylindazol-3-yl)methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

[5-(aminomethyl)-2-methylpiperidin-1-yl]-(1-methylindazol-3-yl)methanone
CID 103120809
(1-methylindazol-3-yl)-pyrrolidin-1-ylmethanone
CID 110848618
[(2S,6R)-2,6-dimethylmorpholin-4-yl]-[4-(1-methylindazol-3-yl)phenyl]methanone
CID 122568773
[3-(hydroxymethyl)pyrrolidin-1-yl]-(1-methylindazol-3-yl)methanone
CID 103120147
[(3R)-3-(hydroxymethyl)pyrrolidin-1-yl]-(1-methylindazol-3-yl)methanone
CID 166081502
[2-(aminomethyl)-6-methylpiperidin-1-yl]-(1-methylindazol-3-yl)methanone
CID 103120794
[2-(aminomethyl)-6-methylmorpholin-4-yl]-(1-methylpyrazol-4-yl)methanone
CID 102938421
(4-bromopiperidin-1-yl)-(1-methylindazol-3-yl)methanone
CID 103122439
[3-(methylamino)pyrrolidin-1-yl]-(1-methylindazol-3-yl)methanone
CID 103121000
4-[(2S,6S)-2,6-dimethylmorpholine-4-carbonyl]-2-propylphthalazin-1-one
CID 2594981
[2-(aminomethyl)-6-methylmorpholin-4-yl]-(2-ethoxyphenyl)methanone
CID 102938261
[3-(4-cyclohexylpiperazin-1-yl)azetidin-1-yl]-(1-methylindazol-3-yl)methanone
CID 126892556

Frequently Asked Questions

What is the IUPAC name of [2-(aminomethyl)-6-methylmorpholin-4-yl]-(1-methylindazol-3-yl)methanone?
The IUPAC name of [2-(aminomethyl)-6-methylmorpholin-4-yl]-(1-methylindazol-3-yl)methanone (CID 103123263) is [2-(aminomethyl)-6-methylmorpholin-4-yl]-(1-methylindazol-3-yl)methanone.
What is the SMILES notation for [2-(aminomethyl)-6-methylmorpholin-4-yl]-(1-methylindazol-3-yl)methanone?
The canonical SMILES for [2-(aminomethyl)-6-methylmorpholin-4-yl]-(1-methylindazol-3-yl)methanone is CC1CN(C(=O)c2nn(C)c3ccccc23)CC(CN)O1.
What is the InChIKey of [2-(aminomethyl)-6-methylmorpholin-4-yl]-(1-methylindazol-3-yl)methanone?
The InChIKey is CQHCYQSJSPATOS-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H20N4O2/c1-10-8-19(9-11(7-16)21-10)15(20)14-12-5-3-4-6-13(12)18(2)17-14/h3-6,10-11H,7-9,16H2,1-2H3.
What are the key properties of [2-(aminomethyl)-6-methylmorpholin-4-yl]-(1-methylindazol-3-yl)methanone?
[2-(aminomethyl)-6-methylmorpholin-4-yl]-(1-methylindazol-3-yl)methanone has a molecular weight of 288.35 g/mol, XLogP of 0.76, 2 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [2-(aminomethyl)-6-methylmorpholin-4-yl]-(1-methylindazol-3-yl)methanone is sourced from PubChem (CID 103123263), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).